Jasper Therapeutics Inc. (JSPR)
undefined
undefined%
At close: undefined

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -64.47M -37.69M -30.64M -31.67M -4.99M
Depreciation & Amortization 1.11M 975.00K 377.00K 21.00K -
Stock-Based Compensation 5.21M 4.09M 1.05M 1.21M 6.00K
Other Working Capital 2.06M 1.50M -1.32M 938.00K 1.39M
Other Non-Cash Items 976.00K -12.59M -9.09M 10.90M 1.62M
Deferred Income Tax - - 3.00M -21.00K -
Change in Working Capital 5.10M -649.00K 1.62M 1.30M 1.39M
Operating Cash Flow -52.07M -45.86M -33.68M -18.27M -1.97M
Capital Expenditures -267.00K -576.00K -2.43M - -
Acquisitions - - - - -
Purchase of Investments - - - - -
Sales Maturities Of Investments - - - - -
Other Investing Acitivies - - - 198.34K -
Investing Cash Flow -267.00K -576.00K -2.43M 198.34K -
Debt Repayment - - - - 1.50M
Common Stock Repurchased - 28.00K - - -
Dividend Paid - - - - -
Other Financial Acitivies -56.00K 55.00K 100.97M 11.29M 27.63M
Financial Cash Flow 100.97M 55.00K 100.97M 11.29M 29.13M
Net Cash Flow 48.64M -46.38M 64.86M -6.98M 27.16M
Free Cash Flow -52.33M -46.43M -36.11M -18.27M -1.97M